Description: Cardio Diagnostics is a biotechnology company that makes cardiovascular disease prevention and early detection more accessible, personalized, and precise. Cardio was formed to further develop and commercialize a proprietary Artificial Intelligence (AI)-driven Integrated Genetic-Epigenetic EngineTM for cardiovascular disease to become one of the leading medical technology companies for enabling improved prevention, early detection, and assists in treatment of cardiovascular disease.
Home Page: cardiodiagnosticsinc.com
CDIO Technical Analysis
400 North Abderdeen Street
Chicago,
IL
60642
United States
Phone:
855-226-9991
Officers
| Name | Title |
|---|---|
| Dr. Meeshanthini Dogan Ph.D. | Co-Founder, CEO & Director |
| Dr. Robert A. Philibert M.D., Ph.D. | Co-Founder, Chief Medical Officer & Director |
| Ms. Elisa Michael Luqman J.D., M.B.A. | CFO & Director |
| Mr. Timur Dogan Ph.D. | Chief Technology Officer |
| Ms. Khullani Abdullah J.D. | VP of Revenue & Strategy |
Exchange: NASDAQ
Country: US
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 1.6376 |
| Price-to-Sales TTM: | 13622.657 |
| IPO Date: | 2022-01-14 |
| Fiscal Year End: | December |
| Full Time Employees: | 4 |